CIDOFOVIR ANHYDROUS

CIDOFOVIR ANHYDROUS was reported 1446 times

CIDOFOVIR ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HERPES SIMPLEX ANORECTAL 2 0.5000
1 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
2 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
3 LARYNGEAL PAPILLOMA 8 0.1702
4 BURKITT'S LYMPHOMA RECURRENT 1 0.1667
5 ACQUIRED MITOCHONDRIAL DNA MUTATION 2 0.1538
6 RESPIRATORY PAPILLOMA 8 0.1455
7 CLEFT LIP REPAIR 1 0.1250
8 ADENOVIRUS REACTIVATION 18 0.1250
9 HEPATITIS E ANTIGEN POSITIVE 1 0.1111
10 AUTOIMMUNE PANCYTOPENIA 10 0.1099
11 VIRAL HAEMORRHAGIC CYSTITIS 76 0.1067
12 ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION 3 0.1000
13 CARTILAGE HYPERTROPHY 2 0.1000
14 VACCINATION SITE INFLAMMATION 5 0.0877
15 NAIL NECROSIS 2 0.0870
16 BK POLYOMAVIRUS TEST POSITIVE 8 0.0833
17 VIRAL UVEITIS 8 0.0825
18 PNEUMONIA ADENOVIRAL 15 0.0758
19 CD4 LYMPHOCYTES 2 0.0741
20 ADENOVIRAL HEPATITIS 17 0.0723
21 RED BLOOD CELL SCHISTOCYTES 1 0.0667
22 HYPOURICAEMIA 19 0.0655
23 SALIVARY GLAND RESECTION 1 0.0625
24 EVAN'S SYNDROME 1 0.0588
25 ADENOVIRUS INFECTION 159 0.0548
26 ADENOVIRAL HAEMORRHAGIC CYSTITIS 10 0.0481
27 PSYCHOPHYSIOLOGIC INSOMNIA 1 0.0455
28 COMA URAEMIC 1 0.0455
29 RESPIROVIRUS TEST POSITIVE 3 0.0441
30 EOSINOPHILIC PUSTULAR FOLLICULITIS 4 0.0430
31 BRONCHIAL OEDEMA 4 0.0426
32 PARVOVIRUS INFECTION 17 0.0421
33 GLOMERULAR FILTRATION RATE 3 0.0411
34 UNDIFFERENTIATED SARCOMA 2 0.0392
35 RENOVASCULAR HYPERTENSION 3 0.0375
36 BK VIRUS INFECTION 125 0.0370
37 ACIDOSIS HYPERCHLORAEMIC 21 0.0354
38 HERPES SIMPLEX TEST POSITIVE 7 0.0352
39 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 44 0.0334
40 MONKEYPOX 9 0.0326
41 BLADDER HYPERTROPHY 14 0.0317
42 HEPATITIS E ANTIBODY POSITIVE 1 0.0286
43 CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER 2 0.0278
44 ENCEPHALITIS CYTOMEGALOVIRUS 12 0.0274
45 RED BLOOD CELL AGGLUTINATION 1 0.0263
46 GLOTTIS CARCINOMA 1 0.0256
47 HUMAN POLYOMAVIRUS INFECTION 13 0.0245
48 TRICHODYSPLASIA SPINULOSA 9 0.0236
49 POLYOMAVIRUS VIRAEMIA 25 0.0235
50 PANCREATITIS VIRAL 1 0.0233
51 UPPER MOTOR NEURONE LESION 5 0.0227
52 VIRAL HEPATITIS CARRIER 2 0.0227
53 ALBUMIN URINE 1 0.0227
54 BLOOD OSMOLARITY ABNORMAL 1 0.0227
55 SUBDURAL EFFUSION 2 0.0217
56 ADENOVIRUS TEST POSITIVE 2 0.0211
57 METAPNEUMOVIRUS PNEUMONIA 2 0.0208
58 HEPATITIS B ANTIGEN POSITIVE 1 0.0208
59 DOUBLE HIT LYMPHOMA 1 0.0200
60 CYSTITIS HAEMORRHAGIC 79 0.0196
61 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 45 0.0192
62 GASTROENTERITIS ADENOVIRUS 3 0.0191
63 CYTOMEGALOVIRUS NEPHRITIS 1 0.0189
64 CYTOMEGALOVIRUS INFECTION REACTIVATION 82 0.0185
65 HERPES SIMPLEX REACTIVATION 7 0.0184
66 ACUTE ENDOCARDITIS 1 0.0182
67 ADENOVIRUS INTERSTITIAL NEPHRITIS 1 0.0179
68 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 24 0.0170
69 CREATININE URINE INCREASED 5 0.0165
70 RENAL TUBULAR INJURY 20 0.0165
71 ADRENAL CORTEX NECROSIS 1 0.0154
72 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
73 SEPTO-OPTIC DYSPLASIA 1 0.0152
74 BILIARY CATHETER INSERTION 1 0.0149
75 CRANIAL NERVE PALSIES MULTIPLE 2 0.0143
76 COLD AGGLUTININS POSITIVE 1 0.0143
77 PARVOVIRUS B19 TEST POSITIVE 1 0.0141
78 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0139
79 CHRONIC PAPILLOMATOUS DERMATITIS 1 0.0137
80 GLYCOSURIA 18 0.0133
81 HUMAN HERPESVIRUS 6 INFECTION 25 0.0132
82 T-LYMPHOCYTE COUNT DECREASED 9 0.0132
83 BLOOD BRAIN BARRIER DEFECT 2 0.0132
84 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 3 0.0130
85 BLOOD BETA-D-GLUCAN INCREASED 4 0.0130
86 CELLS IN URINE 1 0.0130
87 PARENTERAL NUTRITION 3 0.0130
88 ALEXIA 1 0.0123
89 CYTOMEGALOVIRUS VIRAEMIA 54 0.0121
90 NASAL MUCOSAL ULCER 1 0.0120
91 CONGENITAL SPINAL CORD ANOMALY 1 0.0119
92 HYPOTONY OF EYE 5 0.0119
93 JC VIRUS INFECTION 19 0.0119
94 GRAFT VERSUS HOST DISEASE IN SKIN 26 0.0118
95 EPSTEIN-BARR VIRAEMIA 13 0.0117
96 PNEUMOCYSTIS JIROVECII INFECTION 14 0.0117
97 FUSARIUM INFECTION 8 0.0114
98 ABSCESS FUNGAL 2 0.0114
99 PENICILLIUM INFECTION 2 0.0111
100 GENITOURINARY SYMPTOM 2 0.0110
101 INTERSTITIAL GRANULOMATOUS DERMATITIS 2 0.0104
102 PARVOVIRUS B19 INFECTION 9 0.0101
103 CYTOMEGALOVIRUS COLITIS 23 0.0100
104 GASTROENTERITIS NOROVIRUS 13 0.0098
105 CEREBRAL TOXOPLASMOSIS 9 0.0096
106 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 3 0.0096
107 HERPES SIMPLEX 62 0.0095
108 OSMOTIC DEMYELINATION SYNDROME 7 0.0095
109 ADRENALITIS 1 0.0093
110 COMPLEMENT FACTOR ABNORMAL 1 0.0093
111 LARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0093
112 DISSEMINATED CYTOMEGALOVIRAL INFECTION 2 0.0093
113 BACILLUS BACTERAEMIA 1 0.0092
114 RASH SCARLATINIFORM 2 0.0090
115 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0090
116 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 19 0.0089
117 PNEUMONIA CYTOMEGALOVIRAL 17 0.0087
118 INFECTION REACTIVATION 10 0.0087
119 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
120 VIRAEMIA 12 0.0087
121 SOFT TISSUE SARCOMA 3 0.0086
122 IMMUNE RECONSTITUTION SYNDROME 11 0.0085
123 MICROANGIOPATHY 8 0.0085
124 SCEDOSPORIUM INFECTION 6 0.0085
125 BLOOD VISCOSITY INCREASED 5 0.0083
126 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
127 CYTOMEGALOVIRUS GASTRITIS 2 0.0079
128 CYSTITIS VIRAL 3 0.0078
129 ATROPHY OF GLOBE 1 0.0078
130 PAPILLOMA VIRAL INFECTION 12 0.0073
131 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
132 MYOCARDIAL STRAIN 1 0.0072
133 CELL-MEDIATED IMMUNE DEFICIENCY 1 0.0071
134 COMPLICATIONS OF TRANSPLANTED KIDNEY 16 0.0070
135 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
136 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 1 0.0070
137 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 34 0.0068
138 DEVICE COMPUTER ISSUE 2 0.0067
139 ENTEROCOCCAL BACTERAEMIA 7 0.0066
140 ENCEPHALITIS VIRAL 8 0.0066
141 DONOR SPECIFIC ANTIBODY PRESENT 1 0.0065
142 PATHOGEN RESISTANCE 59 0.0065
143 PARAKERATOSIS 2 0.0062
144 BLINDNESS CORTICAL 3 0.0061
145 CHRONIC GRAFT VERSUS HOST DISEASE 22 0.0061
146 NEPHROPATHY TOXIC 67 0.0060
147 EPIDERMODYSPLASIA VERRUCIFORMIS 1 0.0060
148 DRUG RESISTANCE 153 0.0060
149 RENAL HYPERTROPHY 1 0.0058
150 MULTIPLE-DRUG RESISTANCE 18 0.0058
151 NEW ONSET DIABETES AFTER TRANSPLANTATION 1 0.0058
152 ENCEPHALITIS BRAIN STEM 1 0.0058
153 GASTROINTESTINAL VIRAL INFECTION 6 0.0058
154 RHEUMATOID FACTOR NEGATIVE 1 0.0057
155 MENINGOENCEPHALITIS VIRAL 1 0.0056
156 DRUG RESISTANCE MUTATION 1 0.0056
157 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
158 VENOOCCLUSIVE DISEASE 14 0.0056
159 BLOOD IMMUNOGLOBULIN A INCREASED 3 0.0056
160 GRAFT LOSS 4 0.0055
161 CYTOMEGALOVIRUS ANTIGEN POSITIVE 1 0.0055
162 CHOROIDAL DETACHMENT 3 0.0054
163 CENTRAL LINE INFECTION 2 0.0054
164 CYTOMEGALOVIRUS INFECTION 89 0.0053
165 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 44 0.0053
166 PYELONEPHRITIS CHRONIC 1 0.0053
167 BACTERIA STOOL IDENTIFIED 1 0.0053
168 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
169 GENITAL ULCERATION 4 0.0052
170 HAEMORRHAGE URINARY TRACT 13 0.0051
171 ENGRAFTMENT SYNDROME 3 0.0051
172 DYSMETRIA 3 0.0050
173 BLOOD IMMUNOGLOBULIN M INCREASED 3 0.0049
174 URETERAL DISORDER 2 0.0049
175 PYELITIS 1 0.0048
176 BLADDER SPASM 9 0.0048
177 PYRAMIDAL TRACT SYNDROME 2 0.0048
178 APRAXIA 7 0.0047
179 GAZE PALSY 8 0.0047
180 STAPHYLOCOCCAL ABSCESS 3 0.0047
181 RENAL HYPOPLASIA 1 0.0046
182 ACUTE GRAFT VERSUS HOST DISEASE 21 0.0046
183 BONE MARROW TRANSPLANT REJECTION 1 0.0045
184 ANOGENITAL WARTS 4 0.0045
185 CANDIDA SEPSIS 4 0.0045
186 KLEBSIELLA SEPSIS 5 0.0044
187 FEEDING INTOLERANCE 2 0.0044
188 IMMUNE THROMBOCYTOPENIA 20 0.0044
189 ANTERIOR CHAMBER FLARE 1 0.0043
190 OLIGODIPSIA 1 0.0043
191 PNEUMONIA HAEMOPHILUS 2 0.0041
192 SERRATIA INFECTION 3 0.0040
193 INFECTIVE TENOSYNOVITIS 1 0.0040
194 LOWER RESPIRATORY TRACT INFECTION VIRAL 2 0.0040
195 RENAL TUBULAR DISORDER 11 0.0039
196 B-CELL APLASIA 1 0.0039
197 ACQUIRED IMMUNODEFICIENCY SYNDROME 2 0.0039
198 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 3 0.0038
199 CHOLANGITIS INFECTIVE 1 0.0038
200 GRAFT VERSUS HOST DISEASE 27 0.0038
201 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
202 STENOTROPHOMONAS INFECTION 5 0.0037
203 RENAL ABSCESS 3 0.0037
204 CULTURE STOOL POSITIVE 1 0.0036
205 BLOOD CHOLINESTERASE DECREASED 1 0.0036
206 PNEUMOCYSTIS JIROVECI INFECTION 1 0.0036
207 VIRAL LOAD INCREASED 14 0.0036
208 MINERAL DEFICIENCY 1 0.0036
209 ENTEROCOCCAL INFECTION 17 0.0035
210 ASPERGILLUS INFECTION 23 0.0035
211 SECONDARY HYPERTENSION 1 0.0035
212 HYPEROSMOLAR STATE 1 0.0035
213 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
214 PLEOCYTOSIS 2 0.0034
215 CARDIOPULMONARY FAILURE 13 0.0033
216 ENTEROBACTER BACTERAEMIA 1 0.0033
217 PARAINFLUENZAE VIRUS INFECTION 5 0.0033
218 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
219 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
220 COOMBS DIRECT TEST POSITIVE 1 0.0032
221 THROMBOTIC MICROANGIOPATHY 31 0.0032
222 FUNGAEMIA 5 0.0032
223 EPSTEIN-BARR VIRUS TEST POSITIVE 2 0.0032
224 BACTERIAL TRANSLOCATION 1 0.0032
225 TRANSPLANT REJECTION 25 0.0031
226 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
227 CNS VENTRICULITIS 1 0.0031
228 HAEMOPHILUS INFECTION 3 0.0031
229 RENAL TRANSPLANT FAILURE 3 0.0030
230 HISTIOCYTOSIS HAEMATOPHAGIC 9 0.0030
231 CRANIAL NERVE DISORDER 2 0.0029
232 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
233 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
234 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
235 PLASMABLASTIC LYMPHOMA 1 0.0028
236 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
237 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
238 HUMORAL IMMUNE DEFECT 1 0.0027
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 75 0.0026
240 BLOOD BICARBONATE DECREASED 5 0.0026
241 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
242 NEUROBLASTOMA 1 0.0026
243 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
244 CHRONIC ALLOGRAFT NEPHROPATHY 2 0.0026
245 ESCHERICHIA BACTERAEMIA 6 0.0025
246 IRIDOCYCLITIS 8 0.0025
247 GROWTH HORMONE DEFICIENCY 1 0.0025
248 BLADDER PAIN 8 0.0025
249 LYMPHANGITIS 2 0.0025
250 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
251 BASAL GANGLIA HAEMORRHAGE 2 0.0025
252 ANAL ULCER 2 0.0024
253 BACTERAEMIA 29 0.0024
254 CAMPYLOBACTER INFECTION 2 0.0024
255 LYMPHOPROLIFERATIVE DISORDER 7 0.0024
256 BRAIN ABSCESS 6 0.0024
257 GENITAL LESION 1 0.0024
258 BLOOD AMYLASE INCREASED 4 0.0023
259 GLIOSIS 1 0.0023
260 HYPERFERRITINAEMIA 1 0.0023
261 KIDNEY FIBROSIS 4 0.0023
262 CEREBELLAR SYNDROME 5 0.0023
263 HERPES OPHTHALMIC 3 0.0023
264 RENAL TUBULAR ATROPHY 2 0.0023
265 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
266 MALIGNANT TRANSFORMATION 1 0.0022
267 LOCALISED INTRAABDOMINAL FLUID COLLECTION 1 0.0022
268 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
269 NEUROLOGICAL DECOMPENSATION 5 0.0022
270 DYSPHASIA 1 0.0021
271 LYMPHOPENIA 30 0.0021
272 KLEBSIELLA BACTERAEMIA 2 0.0021
273 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
274 KIDNEY TRANSPLANT REJECTION 10 0.0021
275 BLOOD BICARBONATE INCREASED 1 0.0021
276 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 3 0.0021
277 EPIDERMAL NECROSIS 2 0.0021
278 TRANSPLANT FAILURE 5 0.0020
279 ENCEPHALITIS HERPES 1 0.0020
280 ENCEPHALITIS 14 0.0020
281 GENE MUTATION 4 0.0020
282 BLADDER MASS 1 0.0020
283 AUTOIMMUNE HEPATITIS 14 0.0020
284 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
285 ONYCHALGIA 2 0.0020
286 CENTRAL NERVOUS SYSTEM VASCULITIS 1 0.0020
287 BRAIN STEM INFARCTION 2 0.0020
288 IRIS ADHESIONS 1 0.0019
289 VIRAL MUTATION IDENTIFIED 7 0.0019
290 PULMONARY MUCORMYCOSIS 1 0.0019
291 CYTOPENIA 23 0.0019
292 AREFLEXIA 5 0.0019
293 HYPERLACTACIDAEMIA 5 0.0019
294 STREPTOCOCCAL BACTERAEMIA 2 0.0018
295 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
296 INTRAVASCULAR HAEMOLYSIS 1 0.0018
297 OEDEMATOUS PANCREATITIS 1 0.0018
298 APNOEIC ATTACK 1 0.0018
299 RENAL TUBULAR DYSFUNCTION 1 0.0018
300 METHAEMOGLOBINAEMIA 4 0.0017
301 HYPERREFLEXIA 6 0.0017
302 TRANSPLANT DYSFUNCTION 3 0.0017
303 PALATAL DISORDER 1 0.0017
304 CATARACT SUBCAPSULAR 1 0.0016
305 STEM CELL TRANSPLANT 4 0.0016
306 HEPATOBILIARY DISEASE 1 0.0016
307 BONE MARROW TRANSPLANT 3 0.0016
308 HYPERCHLORAEMIA 1 0.0016
309 NECROTISING RETINITIS 1 0.0016
310 BLADDER IRRITATION 1 0.0016
311 BODY HEIGHT BELOW NORMAL 1 0.0016
312 RUPTURED CEREBRAL ANEURYSM 1 0.0015
313 RESTING TREMOR 1 0.0015
314 RHINOVIRUS INFECTION 6 0.0015
315 ACUTE HEPATIC FAILURE 21 0.0015
316 ASPERGILLOSIS 2 0.0015
317 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
318 CYTOKINE STORM 1 0.0015
319 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
320 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 79 0.0014
321 FUNGAL OESOPHAGITIS 1 0.0014
322 STAPHYLOCOCCAL SEPSIS 7 0.0014
323 FANCONI SYNDROME 2 0.0014
324 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
325 NEUROLOGICAL SYMPTOM 8 0.0014
326 ACUTE MYELOID LEUKAEMIA RECURRENT 3 0.0014
327 DYSHIDROTIC ECZEMA 1 0.0014
328 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
329 APALLIC SYNDROME 1 0.0014
330 HYPOGAMMAGLOBULINAEMIA 9 0.0014
331 HEMIANOPIA HOMONYMOUS 1 0.0014
332 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
333 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 3 0.0014
334 CEREBRAL VASOCONSTRICTION 1 0.0014
335 SKIN NECROSIS 7 0.0013
336 LYMPH NODE TUBERCULOSIS 1 0.0013
337 BRAIN STEM SYNDROME 1 0.0013
338 MULTIPLE DRUG THERAPY 1 0.0013
339 LIMB ASYMMETRY 1 0.0013
340 NEPHROPATHY 12 0.0013
341 MYCOPLASMA INFECTION 1 0.0013
342 PAPULE 9 0.0013
343 NON-CARDIAC CHEST PAIN 4 0.0013
344 MUCOSAL INFLAMMATION 33 0.0013
345 VARICELLA 3 0.0013
346 HEPATITIS VIRAL 1 0.0012
347 CHOROIDAL EFFUSION 1 0.0012
348 ENTEROCOCCAL SEPSIS 1 0.0012
349 AUTOIMMUNE DISORDER 12 0.0012
350 BREATH ODOUR 3 0.0012
351 DYSBIOSIS 1 0.0012
352 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
353 CSF PROTEIN INCREASED 1 0.0012
354 QUADRIPARESIS 2 0.0012
355 FUNGAL SEPSIS 1 0.0012
356 NEPHRITIS 4 0.0012
357 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
358 SPLEEN DISORDER 2 0.0012
359 RENAL IMPAIRMENT 98 0.0012
360 RETINITIS 2 0.0012
361 PULMONARY HAEMORRHAGE 9 0.0011
362 PSEUDOMONAL SEPSIS 2 0.0011
363 COAGULOPATHY 19 0.0011
364 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
365 PNEUMOMEDIASTINUM 2 0.0011
366 EXTENSOR PLANTAR RESPONSE 1 0.0011
367 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
368 BLOOD UREA ABNORMAL 1 0.0011
369 PYELOCALIECTASIS 1 0.0010
370 ENTEROCOLITIS 6 0.0010
371 UVEITIS 14 0.0010
372 PYELONEPHRITIS ACUTE 2 0.0010
373 PNEUMONIA FUNGAL 4 0.0010
374 HEPATITIS FULMINANT 3 0.0010
375 AZOTAEMIA 4 0.0010
376 ORGAN FAILURE 4 0.0010
377 DEMYELINATION 4 0.0010
378 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
379 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
380 APLASTIC ANAEMIA 5 0.0010
381 METABOLIC ACIDOSIS 30 0.0009
382 HYDRONEPHROSIS 7 0.0009
383 HAEMATURIA 32 0.0009
384 TEARFULNESS 4 0.0009
385 FACIAL PALSY 2 0.0009
386 HAEMORRHAGIC DISORDER 1 0.0009
387 HAEMODYNAMIC INSTABILITY 7 0.0009
388 PNEUMONITIS 25 0.0009
389 RENAL TUBULAR ACIDOSIS 2 0.0009
390 ACUTE KIDNEY INJURY 140 0.0009
391 ACINETOBACTER INFECTION 1 0.0009
392 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
393 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
394 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
395 HAEMOGLOBINURIA 1 0.0009
396 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
397 DISTRIBUTIVE SHOCK 2 0.0009
398 BLOOD FIBRINOGEN DECREASED 1 0.0009
399 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
400 FOLATE DEFICIENCY 1 0.0009
401 ELECTROLYTE IMBALANCE 10 0.0009
402 BLADDER OPERATION 1 0.0009
403 ENCEPHALOPATHY 21 0.0009
404 CLOSTRIDIUM COLITIS 1 0.0008
405 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
406 SKIN LESION 22 0.0008
407 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
408 IMMUNOSUPPRESSION 7 0.0008
409 KLEBSIELLA INFECTION 4 0.0008
410 PANCYTOPENIA 44 0.0008
411 HEPATITIS 20 0.0008
412 EXFOLIATIVE RASH 2 0.0008
413 CYSTITIS NONINFECTIVE 1 0.0007
414 SKIN DISCOMFORT 2 0.0007
415 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
416 HEPATIC FAILURE 22 0.0007
417 CORNEAL ABRASION 1 0.0007
418 MENINGITIS VIRAL 1 0.0007
419 IMMUNOGLOBULINS DECREASED 1 0.0007
420 BILIARY TRACT DISORDER 1 0.0007
421 HYPERTRANSAMINASAEMIA 5 0.0007
422 SERUM SICKNESS 2 0.0007
423 HEMIPARESIS 12 0.0007
424 METASTASIS 5 0.0007
425 PSEUDOMONAS INFECTION 6 0.0007
426 MENINGITIS BACTERIAL 1 0.0007
427 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
428 HEPATIC LESION 3 0.0007
429 NOROVIRUS INFECTION 1 0.0007
430 BONE CANCER 3 0.0007
431 MUTISM 1 0.0007
432 RESPIRATORY FAILURE 50 0.0007
433 MOUTH HAEMORRHAGE 5 0.0007
434 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
435 ILEUS PARALYTIC 3 0.0007
436 ATYPICAL PNEUMONIA 2 0.0007
437 GASTROINTESTINAL WALL THICKENING 1 0.0007
438 ORAL HERPES 13 0.0007
439 ACNE CYSTIC 2 0.0007
440 IRITIS 2 0.0007
441 PROSTATITIS 2 0.0007
442 PORTAL HYPERTENSION 2 0.0006
443 OSTEOMALACIA 1 0.0006
444 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
445 HEPATITIS E 1 0.0006
446 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
447 PNEUMONIA VIRAL 2 0.0006
448 MALNUTRITION 7 0.0006
449 PANCREATITIS ACUTE 14 0.0006
450 ACUTE LEUKAEMIA 1 0.0006
451 LIVER ABSCESS 2 0.0006
452 CRYPTOCOCCOSIS 1 0.0006
453 LYMPHOCYTE COUNT INCREASED 2 0.0006
454 METABOLIC SYNDROME 1 0.0006
455 ESCHERICHIA INFECTION 5 0.0006
456 ENTEROBACTER INFECTION 1 0.0006
457 SALMONELLOSIS 1 0.0006
458 LEUKAEMIA RECURRENT 1 0.0006
459 ENTERITIS INFECTIOUS 1 0.0006
460 FACIAL PARALYSIS 5 0.0006
461 APLASIA PURE RED CELL 2 0.0006
462 LEFT VENTRICULAR FAILURE 2 0.0006
463 ACUTE SINUSITIS 1 0.0006
464 VIITH NERVE PARALYSIS 2 0.0006
465 MULTI-ORGAN FAILURE 10 0.0006
466 FAILURE TO THRIVE 3 0.0006
467 PUPIL FIXED 1 0.0006
468 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
469 SEPTIC SHOCK 25 0.0006
470 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
471 PHARYNGITIS 7 0.0006
472 JUGULAR VEIN THROMBOSIS 1 0.0006
473 HAEMOLYTIC ANAEMIA 5 0.0006
474 LIVER TRANSPLANT REJECTION 1 0.0006
475 BONE LESION 2 0.0006
476 HYDROCEPHALUS 3 0.0006
477 CONDUCTION DISORDER 1 0.0005
478 LOBAR PNEUMONIA 1 0.0005
479 CANDIDA INFECTION 9 0.0005
480 HEPATIC NECROSIS 2 0.0005
481 RENAL FAILURE 70 0.0005
482 BILE DUCT OBSTRUCTION 1 0.0005
483 ATROPHY 1 0.0005
484 APLASIA 1 0.0005
485 RENAL TUBULAR NECROSIS 5 0.0005
486 RESPIRATORY ACIDOSIS 2 0.0005
487 HYPERAEMIA 1 0.0005
488 ATAXIA 6 0.0005
489 DEVICE RELATED SEPSIS 1 0.0005
490 BREAST DISORDER 1 0.0005
491 DERMATITIS PSORIASIFORM 1 0.0005
492 STAPHYLOCOCCAL INFECTION 16 0.0005
493 CAPILLARY LEAK SYNDROME 1 0.0005
494 SKIN INDURATION 1 0.0005
495 LIVEDO RETICULARIS 1 0.0005
496 PROTEINURIA 9 0.0005
497 RENAL NEOPLASM 1 0.0005
498 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
499 ENTERITIS 3 0.0005
500 FEBRILE NEUTROPENIA 31 0.0005
501 CD4 LYMPHOCYTES DECREASED 1 0.0005
502 HYPERPHOSPHATAEMIA 1 0.0005
503 PARESIS 1 0.0004
504 THERAPY PARTIAL RESPONDER 7 0.0004
505 PSEUDOMEMBRANOUS COLITIS 1 0.0004
506 MYELOSUPPRESSION 16 0.0004
507 SUSPECTED OFF LABEL USE 2 0.0004
508 BLOOD LOSS ANAEMIA 1 0.0004
509 VASCULAR DEVICE INFECTION 2 0.0004
510 TREATMENT FAILURE 36 0.0004
511 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
512 OFF LABEL USE 371 0.0004
513 SKIN ABRASION 2 0.0004
514 PULMONARY INFARCTION 1 0.0004
515 PANCREATITIS CHRONIC 1 0.0004
516 NERVOUS SYSTEM DISORDER 13 0.0004
517 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
518 PAINFUL RESPIRATION 1 0.0004
519 FLUID OVERLOAD 6 0.0004
520 INCORRECT DOSAGE ADMINISTERED 2 0.0004
521 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
522 GLOMERULONEPHRITIS 1 0.0004
523 DYSURIA 15 0.0004
524 HYPOPHOSPHATAEMIA 3 0.0004
525 ORGANISING PNEUMONIA 2 0.0004
526 SEPSIS 45 0.0004
527 GASTROINTESTINAL TUBE INSERTION 1 0.0004
528 DERMATITIS EXFOLIATIVE 2 0.0004
529 DYSARTHRIA 15 0.0004
530 BLOOD CREATININE INCREASED 26 0.0004
531 MENTAL STATUS CHANGES 11 0.0004
532 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
533 BONE MARROW FAILURE 8 0.0004
534 LIPASE INCREASED 3 0.0004
535 HEPATOSPLENOMEGALY 1 0.0004
536 BLOOD CHLORIDE DECREASED 1 0.0004
537 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
538 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
539 MUCORMYCOSIS 1 0.0004
540 GASTROINTESTINAL INFLAMMATION 3 0.0004
541 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
542 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
543 LUNG OPACITY 1 0.0004
544 HEPATIC FUNCTION ABNORMAL 14 0.0004
545 VIROLOGIC FAILURE 2 0.0004
546 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
547 BLOOD SODIUM INCREASED 1 0.0004
548 LACTIC ACIDOSIS 12 0.0004
549 BLOOD PHOSPHORUS INCREASED 1 0.0004
550 APPLICATION SITE HAEMORRHAGE 1 0.0004
551 NECROSIS 2 0.0004
552 COORDINATION ABNORMAL 5 0.0004
553 ANGIOPATHY 2 0.0004
554 SKIN HYPERTROPHY 1 0.0004
555 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
556 PNEUMATOSIS INTESTINALIS 1 0.0004
557 DUODENAL ULCER HAEMORRHAGE 1 0.0003
558 PARALYSIS 5 0.0003
559 HYPERTONIA 2 0.0003
560 LIP PAIN 1 0.0003
561 HERPES VIRUS INFECTION 2 0.0003
562 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
563 BILIARY COLIC 1 0.0003
564 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
565 VASCULITIS 4 0.0003
566 HYPERTRIGLYCERIDAEMIA 2 0.0003
567 BONE MARROW DISORDER 1 0.0003
568 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
569 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
570 FIBROSIS 1 0.0003
571 NEUTROPENIA 44 0.0003
572 PRODUCT PRESCRIBING ISSUE 7 0.0003
573 DIARRHOEA HAEMORRHAGIC 3 0.0003
574 PNEUMONIA ASPIRATION 8 0.0003
575 BLOOD CREATININE DECREASED 1 0.0003
576 LEUKAEMIA 3 0.0003
577 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
578 COLITIS 12 0.0003
579 HEPATOTOXICITY 7 0.0003
580 BACTERIAL SEPSIS 1 0.0003
581 SHOCK 7 0.0003
582 ORAL CANDIDIASIS 4 0.0003
583 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
584 CYTOLYTIC HEPATITIS 1 0.0003
585 RESPIRATORY DISORDER 9 0.0003
586 CLOSTRIDIAL INFECTION 1 0.0003
587 NEPHROTIC SYNDROME 2 0.0003
588 HYPERBILIRUBINAEMIA 3 0.0003
589 BLOOD CREATININE ABNORMAL 1 0.0003
590 NECROTISING FASCIITIS 1 0.0003
591 HEART DISEASE CONGENITAL 1 0.0003
592 GLOSSITIS 1 0.0003
593 FIBRIN D DIMER INCREASED 1 0.0003
594 HAEMORRHAGIC DIATHESIS 1 0.0003
595 LEUKOPENIA 14 0.0003
596 RENAL DISORDER 13 0.0003
597 DISEASE PROGRESSION 33 0.0003
598 C-REACTIVE PROTEIN INCREASED 10 0.0003
599 MAJOR DEPRESSION 2 0.0003
600 BLOOD PHOSPHORUS DECREASED 1 0.0003
601 FOOD INTOLERANCE 1 0.0003
602 CARDIAC DYSFUNCTION 1 0.0003
603 LEUKOENCEPHALOPATHY 1 0.0003
604 RETINOPATHY 1 0.0003
605 SKIN INFECTION 3 0.0003
606 THERAPY NON-RESPONDER 12 0.0003
607 STATUS EPILEPTICUS 3 0.0003
608 EPILEPSY 8 0.0003
609 RENAL FAILURE CHRONIC 2 0.0003
610 METASTASES TO LUNG 3 0.0003
611 PERICARDIAL EFFUSION 6 0.0003
612 BLOOD BILIRUBIN INCREASED 7 0.0003
613 LYMPHOMA 4 0.0003
614 ACUTE MYELOID LEUKAEMIA 4 0.0003
615 LYMPHADENOPATHY 9 0.0003
616 RESPIRATORY DISTRESS 7 0.0003
617 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
618 DISEASE RECURRENCE 12 0.0003
619 BLOOD ALBUMIN DECREASED 2 0.0003
620 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
621 NO THERAPEUTIC RESPONSE 3 0.0002
622 SHOCK HAEMORRHAGIC 2 0.0002
623 ARTHRITIS BACTERIAL 1 0.0002
624 HYPERURICAEMIA 1 0.0002
625 SECOND PRIMARY MALIGNANCY 2 0.0002
626 HEMIPLEGIA 2 0.0002
627 BLOOD UREA INCREASED 4 0.0002
628 ASCITES 7 0.0002
629 HYPERPYREXIA 1 0.0002
630 RENAL FAILURE ACUTE 10 0.0002
631 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
632 CIRCULATORY COLLAPSE 4 0.0002
633 THROMBOCYTOPENIA 26 0.0002
634 ANURIA 2 0.0002
635 PYELONEPHRITIS 2 0.0002
636 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
637 HYPERKALAEMIA 8 0.0002
638 BLOOD CREATINE INCREASED 1 0.0002
639 PRODUCT USE ISSUE 42 0.0002
640 TACHYPNOEA 3 0.0002
641 END STAGE RENAL DISEASE 4 0.0002
642 PNEUMONIA BACTERIAL 2 0.0002
643 RETINAL DETACHMENT 2 0.0002
644 DRUG INEFFECTIVE 286 0.0002
645 GRAND MAL CONVULSION 2 0.0002
646 SEIZURE 25 0.0002
647 NEPHROGENIC ANAEMIA 1 0.0002
648 HYPOMAGNESAEMIA 3 0.0002
649 GASTRITIS EROSIVE 1 0.0002
650 STOMATITIS 13 0.0002
651 HEPATIC ENCEPHALOPATHY 2 0.0002
652 HYPOVOLAEMIC SHOCK 1 0.0002
653 FAECAL INCONTINENCE 1 0.0002
654 PANCREATITIS 11 0.0002
655 APHAGIA 1 0.0002
656 CARDIAC ARREST 17 0.0002
657 HEPATOMEGALY 2 0.0002
658 HYPERVOLAEMIA 1 0.0002
659 BLADDER DISORDER 2 0.0002
660 ABDOMINAL TENDERNESS 1 0.0002
661 HYPERNATRAEMIA 1 0.0002
662 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
663 PATHOLOGICAL FRACTURE 1 0.0002
664 CACHEXIA 1 0.0002
665 BLOOD LACTIC ACID INCREASED 1 0.0002
666 LIVER FUNCTION TEST INCREASED 4 0.0002
667 CHEILITIS 1 0.0002
668 TOXICITY TO VARIOUS AGENTS 31 0.0002
669 PLEURAL EFFUSION 11 0.0002
670 TYPE 2 DIABETES MELLITUS 6 0.0002
671 SCAB 2 0.0002
672 BLINDNESS 7 0.0002
673 NEUROTOXICITY 3 0.0002
674 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
675 HYPOVOLAEMIA 1 0.0002
676 HYPOXIA 6 0.0002
677 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
678 ODYNOPHAGIA 1 0.0002
679 PROTHROMBIN TIME PROLONGED 1 0.0002
680 HEPATITIS CHOLESTATIC 1 0.0002
681 HEPATITIS B 1 0.0002
682 HYPERGLYCAEMIA 6 0.0002
683 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
684 THROMBOSIS 13 0.0002
685 GENERALISED OEDEMA 2 0.0002
686 AGRANULOCYTOSIS 3 0.0002
687 CHOLANGITIS 1 0.0002
688 BACTERIAL INFECTION 3 0.0002
689 CHRONIC KIDNEY DISEASE 12 0.0002
690 CYSTITIS 5 0.0002
691 DIPLOPIA 4 0.0002
692 HEPATITIS ACUTE 1 0.0002
693 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
694 HAEMORRHAGE 16 0.0002
695 CARDIAC FAILURE ACUTE 1 0.0001
696 MENINGITIS 1 0.0001
697 BREAST MASS 1 0.0001
698 BRONCHIECTASIS 1 0.0001
699 INFARCTION 1 0.0001
700 HALLUCINATION 11 0.0001
701 ECCHYMOSIS 1 0.0001
702 PULMONARY HYPERTENSION 3 0.0001
703 PULMONARY TOXICITY 1 0.0001
704 DIALYSIS 2 0.0001
705 RETINAL HAEMORRHAGE 1 0.0001
706 NEUTROPENIC SEPSIS 1 0.0001
707 SUBDURAL HAEMATOMA 2 0.0001
708 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
709 MENTAL DISORDER 6 0.0001
710 ORAL DISORDER 1 0.0001
711 ANAEMIA 26 0.0001
712 PYREXIA 47 0.0001
713 PSYCHIATRIC SYMPTOM 1 0.0001
714 RASH MACULO-PAPULAR 3 0.0001
715 CONDITION AGGRAVATED 41 0.0001
716 PULMONARY MASS 2 0.0001
717 HAEMORRHAGE INTRACRANIAL 2 0.0001
718 DEPRESSED MOOD 7 0.0001
719 HYPERTHERMIA 1 0.0001
720 ACIDOSIS 1 0.0001
721 HYPOKALAEMIA 6 0.0001
722 HYPOALBUMINAEMIA 1 0.0001
723 COGNITIVE DISORDER 6 0.0001
724 PNEUMOTHORAX 2 0.0001
725 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
726 ATRIAL FLUTTER 1 0.0001
727 SENSORY LOSS 1 0.0001
728 INTERSTITIAL LUNG DISEASE 6 0.0001
729 DECUBITUS ULCER 1 0.0001
730 POLYURIA 1 0.0001
731 VENTRICULAR TACHYCARDIA 2 0.0001
732 HAEMODIALYSIS 1 0.0001
733 HAEMATEMESIS 3 0.0001
734 HYPERTENSION 25 0.0001
735 HYPOPHAGIA 3 0.0001
736 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
737 GASTRIC DISORDER 4 0.0001
738 SKIN ULCER 3 0.0001
739 PSYCHOLOGICAL TRAUMA 1 0.0001
740 GASTRITIS 3 0.0001
741 LUNG INFILTRATION 1 0.0001
742 RESPIRATORY RATE INCREASED 1 0.0001
743 PNEUMONIA 36 0.0001
744 DEVELOPMENTAL DELAY 1 0.0001
745 LEUKOCYTOSIS 2 0.0001
746 PELVIC PAIN 2 0.0001
747 HYPOTENSION 22 0.0001
748 INCREASED TENDENCY TO BRUISE 1 0.0001
749 HAEMOPTYSIS 3 0.0001
750 DRUG INTERACTION 17 0.0001
751 DEFORMITY 1 0.0001
752 HYPOCALCAEMIA 2 0.0001
753 PULMONARY EMBOLISM 10 0.0001
754 COMA 5 0.0001
755 EYE INFLAMMATION 1 0.0001
756 LETHARGY 6 0.0001
757 CHOLESTASIS 2 0.0001
758 ACUTE RESPIRATORY FAILURE 2 0.0001
759 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
760 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
761 DISORIENTATION 4 0.0001
762 BRAIN INJURY 1 0.0001
763 CYTOKINE RELEASE SYNDROME 2 0.0001
764 HYPOTHERMIA 1 0.0001
765 MOTOR DYSFUNCTION 1 0.0001
766 CARDIO-RESPIRATORY ARREST 4 0.0001
767 DYSPHAGIA 9 0.0001
768 INCONTINENCE 1 0.0001
769 HYPOACUSIS 4 0.0001
770 SKIN CANCER 2 0.0001
771 TREATMENT NONCOMPLIANCE 5 0.0001
772 MELAENA 2 0.0001
773 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
774 LIVER DISORDER 4 0.0001
775 FUNGAL INFECTION 3 0.0001
776 NERVE INJURY 1 0.0001
777 INFECTION 13 0.0001
778 GLOSSODYNIA 2 0.0001
779 HYPONATRAEMIA 5 0.0001
780 CONVULSION 5 0.0001
781 MYOCARDITIS 1 0.0001
782 SEXUAL DYSFUNCTION 1 0.0001
783 PRODUCT PRESCRIBING ERROR 2 0.0001
784 CHOLECYSTITIS 1 0.0001
785 MYOCLONUS 1 0.0001
786 HYPERLIPIDAEMIA 1 0.0001
787 HEPATITIS C 1 0.0001
788 MENTAL IMPAIRMENT 2 0.0001
789 NEURALGIA 2 0.0001
790 LIVER INJURY 2 0.0001
791 EXTRAPYRAMIDAL DISORDER 2 0.0001
792 ILEUS 1 0.0001
793 BRAIN OEDEMA 1 0.0001
794 GASTROINTESTINAL DISORDER 7 0.0001
795 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
796 INFUSION SITE PAIN 1 0.0001
797 INFLAMMATION 4 0.0001
798 PLATELET COUNT INCREASED 1 0.0001
799 BEDRIDDEN 1 0.0001
800 ABNORMAL BEHAVIOUR 3 0.0001
801 EYE HAEMORRHAGE 1 0.0001
802 CARDIAC FAILURE CONGESTIVE 6 0.0001
803 JOINT RANGE OF MOTION DECREASED 1 0.0001
804 SOMNOLENCE 15 0.0001
805 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
806 DRUG TOXICITY 1 0.0001
807 GINGIVAL BLEEDING 1 0.0001
808 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
809 RESPIRATORY ARREST 2 0.0001
810 FEELING COLD 2 0.0001
811 APHONIA 1 0.0001
812 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
813 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
814 CONFUSIONAL STATE 11 0.0001
815 TACHYCARDIA 6 0.0001
816 URINARY INCONTINENCE 2 0.0001
817 WHEEZING 4 0.0001
818 RENAL INJURY 2 0.0001
819 PULMONARY OEDEMA 3 0.0001
820 BLOOD POTASSIUM DECREASED 2 0.0001
821 APHASIA 2 0.0001
822 VOMITING 31 0.0001
823 DEVICE RELATED INFECTION 1 0.0001
824 ANKLE FRACTURE 1 0.0001
825 LUNG INFECTION 1 0.0001
826 DRUG-INDUCED LIVER INJURY 2 0.0001
827 INFLUENZA 7 0.0001
828 OBESITY 1 0.0001
829 ABSCESS 1 0.0001
830 MUSCLE TIGHTNESS 1 0.0001
831 BLOOD POTASSIUM INCREASED 1 0.0001
832 PHOTOSENSITIVITY REACTION 1 0.0001
833 DIARRHOEA 39 0.0001
834 DRUG LEVEL INCREASED 1 0.0001
835 VIRAL INFECTION 2 0.0001
836 CELLULITIS 3 0.0001
837 URINARY TRACT INFECTION 10 0.0001
838 SCAR 1 0.0001
839 NEOPLASM PROGRESSION 2 0.0001
840 SPEECH DISORDER 3 0.0001
841 BRADYCARDIA 3 0.0001
842 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
843 CEREBRAL HAEMORRHAGE 2 0.0001
844 OSTEOMYELITIS 1 0.0001
845 BONE DISORDER 1 0.0001
846 AGITATION 4 0.0001
847 ANAPHYLACTIC REACTION 3 0.0001
848 BLISTER 3 0.0001
849 OXYGEN SATURATION DECREASED 3 0.0001
850 PHOTOPHOBIA 1 0.0001
851 BLOOD SODIUM DECREASED 1 0.0001
852 BLOOD URINE PRESENT 1 0.0001
853 GASTRIC ULCER 1 0.0001
854 HERPES ZOSTER 3 0.0001
855 POST PROCEDURAL COMPLICATION 1 0.0001
856 DECREASED APPETITE 12 0.0001
857 HAEMORRHOIDS 1 0.0001
858 KIDNEY INFECTION 1 0.0001
859 PREGNANCY 1 0.0000
860 CARDIAC FAILURE 4 0.0000
861 THERAPEUTIC RESPONSE DECREASED 3 0.0000
862 ILL-DEFINED DISORDER 3 0.0000
863 BODY TEMPERATURE INCREASED 1 0.0000
864 HAEMOGLOBIN DECREASED 5 0.0000
865 PERITONITIS 1 0.0000
866 POLLAKIURIA 2 0.0000
867 CEREBROVASCULAR ACCIDENT 8 0.0000
868 RETCHING 1 0.0000
869 DEEP VEIN THROMBOSIS 3 0.0000
870 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
871 COLITIS ULCERATIVE 2 0.0000
872 HEART RATE IRREGULAR 1 0.0000
873 PRODUCT AVAILABILITY ISSUE 1 0.0000
874 MUSCLE TWITCHING 1 0.0000
875 CHILLS 5 0.0000
876 MOBILITY DECREASED 3 0.0000
877 NAUSEA 33 0.0000
878 HYPOGLYCAEMIA 2 0.0000
879 ABASIA 1 0.0000
880 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
881 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
882 ERECTILE DYSFUNCTION 1 0.0000
883 ABDOMINAL PAIN 9 0.0000
884 HAEMATOMA 1 0.0000
885 RESPIRATORY TRACT INFECTION 1 0.0000
886 SEDATION 1 0.0000
887 ANHEDONIA 1 0.0000
888 JAUNDICE 1 0.0000
889 PAIN OF SKIN 1 0.0000
890 FREQUENT BOWEL MOVEMENTS 1 0.0000
891 LIMB INJURY 1 0.0000
892 PALLOR 1 0.0000
893 MEMORY IMPAIRMENT 5 0.0000
894 HAEMATOCHEZIA 2 0.0000
895 COUGH 10 0.0000
896 RASH 15 0.0000
897 LIVER FUNCTION TEST ABNORMAL 1 0.0000
898 INTENTIONAL PRODUCT MISUSE 3 0.0000
899 DYSSTASIA 1 0.0000
900 IRRITABILITY 2 0.0000
901 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
902 MOVEMENT DISORDER 1 0.0000
903 DRUG INTOLERANCE 3 0.0000
904 CHOLELITHIASIS 1 0.0000
905 OSTEONECROSIS 1 0.0000
906 EYE DISORDER 1 0.0000
907 HEADACHE 19 0.0000
908 SKIN DISORDER 1 0.0000
909 SINUSITIS 3 0.0000
910 ASTHENIA 11 0.0000
911 NIGHTMARE 1 0.0000
912 INJURY 2 0.0000
913 SLEEP DISORDER 2 0.0000
914 DRUG EFFECT INCOMPLETE 1 0.0000
915 UNDERDOSE 2 0.0000
916 RESTLESSNESS 1 0.0000
917 DYSGEUSIA 2 0.0000
918 EPISTAXIS 2 0.0000
919 DYSPNOEA EXERTIONAL 1 0.0000
920 INTESTINAL OBSTRUCTION 1 0.0000
921 DEPRESSION 6 0.0000
922 DIABETES MELLITUS 2 0.0000
923 WEIGHT DECREASED 7 0.0000
924 OEDEMA PERIPHERAL 3 0.0000
925 DYSKINESIA 1 0.0000
926 OSTEOPOROSIS 1 0.0000
927 VISUAL IMPAIRMENT 3 0.0000
928 TREMOR 4 0.0000
929 FALL 8 0.0000
930 SKIN EXFOLIATION 2 0.0000
931 OSTEOARTHRITIS 1 0.0000
932 MYALGIA 4 0.0000
933 BALANCE DISORDER 2 0.0000
934 CONSTIPATION 5 0.0000
935 COVID-19 4 0.0000
936 NO ADVERSE EVENT 4 0.0000
937 SKIN IRRITATION 1 0.0000
938 NEPHROLITHIASIS 1 0.0000
939 MUSCLE SPASMS 4 0.0000
940 SKIN DISCOLOURATION 1 0.0000
941 PRODUCTIVE COUGH 1 0.0000
942 GAIT DISTURBANCE 4 0.0000
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
944 ATRIAL FIBRILLATION 2 0.0000
945 LUNG DISORDER 1 0.0000
946 DRY EYE 1 0.0000
947 DYSPNOEA 11 0.0000
948 ECZEMA 1 0.0000
949 PARAESTHESIA 3 0.0000
950 PLATELET COUNT DECREASED 2 0.0000
951 DRUG EFFECT DECREASED 1 0.0000
952 MEDICATION ERROR 1 0.0000
953 MUSCULAR WEAKNESS 2 0.0000
954 DEATH 15 0.0000
955 DYSPHONIA 1 0.0000
956 NASAL CONGESTION 1 0.0000
957 CATARACT 1 0.0000
958 FATIGUE 13 0.0000
959 FEELING HOT 1 0.0000
960 HYPERSENSITIVITY 3 0.0000
961 RHINORRHOEA 1 0.0000
962 AMNESIA 1 0.0000
963 DEHYDRATION 2 0.0000
964 HEPATIC ENZYME INCREASED 1 0.0000
965 ERYTHEMA 3 0.0000
966 BRONCHITIS 1 0.0000
967 ARTHRITIS 1 0.0000
968 DRY MOUTH 1 0.0000
969 ABDOMINAL DISCOMFORT 2 0.0000
970 MUSCULOSKELETAL STIFFNESS 1 0.0000
971 PAIN 7 0.0000
972 OROPHARYNGEAL PAIN 1 0.0000
973 NEUROPATHY PERIPHERAL 1 0.0000
974 PAIN IN EXTREMITY 3 0.0000
975 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
976 ABDOMINAL DISTENSION 1 0.0000
977 OVERDOSE 2 0.0000
978 WEIGHT INCREASED 2 0.0000
979 ASTHMA 1 0.0000
980 BACK PAIN 2 0.0000
981 DIZZINESS 4 0.0000
982 LOSS OF CONSCIOUSNESS 1 0.0000
983 DRY SKIN 1 0.0000
984 MALAISE 3 0.0000
985 HOSPITALISATION 1 0.0000
986 DRUG DOSE OMISSION 1 0.0000
987 BLOOD GLUCOSE INCREASED 1 0.0000
988 INSOMNIA 1 0.0000
989 ANXIETY 1 0.0000
990 PRODUCT DOSE OMISSION ISSUE 1 0.0000
991 PRURITUS 1 0.0000
992 ARTHRALGIA 1 0.0000